✓ Credit card payment restored — secure checkout via Privacy Shield
Morgan Ellis, pharmacy researcher and medical reviewer at MedsBase

Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Verdict: Is AllDayChemist legit?

Yes — AllDayChemist is a legitimate international online pharmacy. Operating since approximately 2002, they are one of the oldest India-based generic exporters and do ship genuine WHO-GMP certified medications. You are unlikely to receive counterfeit product from them.

However, “legit” and “best option” are not the same thing. Where AllDayChemist consistently falls short versus alternatives:

  • Payment options are limited — credit card acceptance has historically been inconsistent; many customers are pushed toward cryptocurrency or wire transfer, which carry zero chargeback rights.
  • No published reshipment assurance policy — reshipment decisions are handled case-by-case with no public commitment to timeline or coverage scope.
  • Thinner clinical content — product pages are typically short listings without mechanism-of-action, interaction tables, or FAQ schema. Their blog posts on tretinoin, ivermectin, and sildenafil jelly rank in positions 10–19 on Google — signalling thin topical depth.
  • Statement descriptor opacity — some customers report their bank statement shows unexpected merchant names without prior explanation of what to expect.

The rest of this guide explains the four criteria that separate a well-run international pharmacy from a mediocre one — and shows exactly how MedsBase scores on each.

CriterionAllDayChemistMedsBase
Credit card paymentInconsistent — often crypto/wire only✅ Always available via Privacy Shield
Statement descriptorNot publicly documented in advance✅ Processor name only — explained before checkout
Reshipment policyCase-by-case, no public page✅ Written policy — 20 business days, every order covered
Product page clinical depthShort listings, limited FAQ content✅ Mechanism + dosing + interactions + 11-question FAQ per product
Manufacturer transparencyWHO-GMP certified ✅✅ WHO-GMP certified — named manufacturers (Cipla, Sun, Lupin, Ajanta)
Loyalty programmeBasic coupon codes✅ Points (1pt/$1), referral $10/$10, 15% winback at 90/180/365 days
Operating since~2002 ✅✅ Established, 1,400+ verified customers

Key takeaways

  • If you’re searching for an AllDayChemist alternative, the criteria that matter most are payment options, shipping accountability, product range, and regulatory transparency — not just price.
  • The international generic-pharmacy landscape is dominated by India-based exporters. Quality varies widely. Cheap is not the same as legitimate.
  • MedsBase ships from WHO-GMP-certified manufacturers, accepts credit cards (via Privacy Shield), SEPA, and crypto, and covers every order with a written Reshipment Assurance Policy.
  • This guide explains what to look for in any international online pharmacy, then compares MedsBase against the realistic alternative profile.

AllDayChemist Alternatives: What to Look for in an International Online Pharmacy (2026)

If you’ve landed here, you’re probably comparing AllDayChemist with other international generic-pharmacy options — or you’ve already had an issue with one and are looking for something more reliable. This guide doesn’t trash any specific competitor. It explains the four criteria that genuinely separate well-run international generic pharmacies from poorly-run ones, and shows where MedsBase fits.

Why people search for AllDayChemist alternatives

The international generic-pharmacy category exists because authentic, FDA-equivalent generic medication costs five to fifteen times less in India than it does in the US, UK, or EU. Sites like AllDayChemist and MedsBase exist to bridge that gap. The category is real, and serves real demand — particularly for chronic conditions where insurance won’t fully cover branded medication, for time-sensitive needs where domestic prescribing wait-lines are months long, and for niche use cases (research peptides, post-cycle therapy, off-label dermatology) that telehealth refuses to write.

That said, the category has problems. The most common complaints we see across forums and review sites are:

  • Forced cryptocurrency or wire-transfer payments, with no recourse if the order doesn’t arrive. Customers who are first-time buyers find this terrifying — and rightly so.
  • Vague or non-existent reshipment policies. Standard practice in this segment is “case-by-case at our discretion” — which usually means a long support email back-and-forth and often a refund denial.
  • Customer data leakage. Several forum threads describe customers receiving a sudden flood of pharmacy spam in the weeks after placing a single order with a discount international pharmacy. This is consistent with low-grade vendor-network data sharing.
  • Outdated product pages with stale shipping promises (“free shipping over $200”, “express tracked delivery”) that don’t actually reflect operational reality.

If any of those have been your experience, the criteria below are the ones to weight when choosing your next pharmacy.

The four criteria that actually matter

1. Payment options that match the level of trust you can give a brand

The single most important question to ask a new pharmacy is: “What happens if my package never arrives, and how do I get my money back?”

That question has very different answers depending on payment method:

  • Credit card — your card issuer’s chargeback rights apply. If the merchant doesn’t deliver and refuses a refund, you can dispute the charge and the issuer rules in your favour. This is the strongest consumer protection that exists for online purchases.
  • SEPA bank transfer — protections vary by EU country, but the audit trail is there. Your bank knows who received the money.
  • Cryptocurrency — once you send Bitcoin or USDT, it’s gone. There is no chargeback. The only recourse is the merchant’s voluntary refund policy.
  • Wire transfer — same as crypto for practical purposes. International wires are extremely difficult to reverse once cleared.

Pharmacies that accept only crypto and wire transfers are deliberately operating in the zero-recourse zone. There are legitimate reasons (high merchant-account decline rates for the category) but the burden falls entirely on the customer to trust the brand without any external safeguard.

What MedsBase offers: credit card payments via Privacy Shield (a regulated crypto on-ramp processor — your statement shows the processor name, not “MedsBase” or any medication name), SEPA bank transfer (zero fees for EU customers), and direct cryptocurrency via Plisio for customers who prefer it. Three real options, and the most popular by an order of magnitude is the credit card path.

2. A written reshipment policy you can read before ordering

Loss rates on India-to-Western-country international shipping are non-zero. EMS and ITPS courier services are reliable but customs delays, address errors, and rare lost-package events happen. A pharmacy that’s serious about its customer relationship has a clear, written policy for what happens when it does.

The questions to ask:

  • How many business days from dispatch before they’ll consider the package lost?
  • What happens then — full reshipment, partial reshipment, refund, or store credit?
  • Are any product categories excluded?
  • What customer-side situations (wrong address provided, customs seizure due to declared content) reduce the coverage?

If a pharmacy can’t or won’t put the answers in writing on a public page, you’re effectively trusting their goodwill on a high-stakes transaction.

What MedsBase offers: the Reshipment Assurance Policy is published in full and updated as the operational reality changes. Twenty business days from dispatch is the trigger. Every order is covered. Customer-fault exclusions (wrong address, refused delivery) are documented honestly, with a 30% goodwill discount available even in those cases. Refunds remain at the company’s discretion but are issued in genuine edge cases.

3. Product depth and clinical accuracy on the actual product pages

Two pharmacies can list the same medication and have wildly different content quality on the product page. Look for:

  • The active ingredient and strength stated clearly at the top, not buried under marketing copy.
  • An interactions and contraindications section that reflects current clinical guidelines — not generic boilerplate copied across every drug class.
  • Honest warnings on medications with real safety issues. Ranitidine (Zantac/Aciloc/Rantac) was withdrawn from US/EU markets in 2020 over NDMA carcinogen contamination. A pharmacy that still lists it without a warning red-box is either uninformed or deliberately misleading customers.
  • Comparison tables and decision shortcuts on category pages so you can pick between similar molecules without reading every product page.
  • Realistic dosing tables — not blanket “take with water” copy that ignores PPI vs antihistamine vs ED-medication-specific timing.

If a product page reads like generic SEO content, it probably is. The pharmacy’s clinical seriousness is visible in the writing.

What MedsBase offers: over 1,500 product pages with consistent Tier-1 structure — TL;DR Quick Answer, mechanism, dosing, side effects, interactions, contraindications, an 11-question FAQ block, and trust + reshipment information. Where there’s a clinical safety issue (ranitidine, isotretinoin, atypical antipsychotics, peptides without prescription oversight) the page leads with a red-box warning. Listicle comparison hubs cover ED pills, finasteride brands, Ozempic alternatives, peptides, and PrEP.

4. Regulatory transparency about what kind of pharmacy this actually is

No India-export online pharmacy holds LegitScript certification or NABP accreditation. Both certifications require the operator to be a US-licensed pharmacy with US prescription verification — by definition, the international generic export model can’t qualify. Any pharmacy in this segment that claims either certification is misrepresenting itself.

What you can reasonably expect instead:

  • WHO-GMP-certified manufacturer sourcing — these are India FDA / CDSCO-licensed facilities meeting the World Health Organization Good Manufacturing Practice standard. Mainstream branded generics (Cipla, Sun Pharma, Dr Reddy’s, Lupin, Ajanta) are all WHO-GMP. This is real regulatory information.
  • Honest framing about the regulatory model. The pharmacy ships from India under the export model. It is legal where it operates. It does not require a prescription. It is not a US-licensed pharmacy.
  • Active customer service reachable on multiple channels (email, Telegram, contact form) with named staff who actually respond.

Pharmacies that obscure these facts — or that make claims they can’t back up like “FDA-approved” without context, “no risk”, or “100% guaranteed delivery” — are not the ones to choose.

What MedsBase offers: sourcing exclusively from WHO-GMP-certified manufacturers, transparent about the regulatory model, customer service via email at [email protected] and Telegram at @medsbase1.

Quick comparison: what to look for vs what’s typical

CriterionTypical low-tierWhat to demand
Payment optionsBitcoin / wire only, no cardsCredit card via regulated processor + SEPA + crypto
Reshipment policyCase-by-case, no public pageWritten, public, every order covered
Product page depthGeneric stock copy, no FAQ schemaMechanism + dosing + interactions + 11-question FAQ
Safety warningsNo red-box on withdrawn drugsNDMA warning on ranitidine, optic-neuritis warning on ethambutol, etc.
Sourcing transparency“Indian generics manufacturer” — vagueWHO-GMP-certified manufacturers, named (Cipla, Sun, Lupin, Ajanta, etc.)
Statement descriptorMay show pharmacy name on bank statementDiscreet processor name (a regulated card-payment processor)
Support channelsContact form only, slow repliesEmail + Telegram, named human responders
Loyalty / re-purchaseGeneric referral codesEarn-and-redeem points, refill reminder, dormant-customer winback

What MedsBase looks like in practice

Rather than a marketing pitch, a few concrete examples of what a typical MedsBase customer experience looks like:

  • Place an order with a credit card. Your statement will show the regulated processor name (one of a regulated card-payment processor — never “MedsBase” or a medication name). Privacy Shield routes the charge through a regulated crypto on-ramp; your card data never touches MedsBase systems.
  • Receive shipment confirmation in 24-48 hours with an EMS or ITPS tracking number that works on 17track.net or aftership.com.
  • Typical delivery is 10-14 business days for non-EU orders and 3-5 business days from the EU warehouse for in-stock EU items.
  • If your package hasn’t arrived in 20 business days, the Reshipment Assurance Policy automatically applies — email or Telegram for a free reshipment.
  • Earn 1 loyalty point per $1 of product value. Redeem at 100 points = $5 off, with a $50 minimum cart. Points are earned on order completion, peptides excluded, and stack-free with the standard discount coupons.
  • If you don’t reorder for 90 days, you’ll get a COMEBACK15 winback email with a 15% personal coupon. Twice more at 180 and 365 days. Each is a fresh code, individual-use, with no per-user usage limit.

What MedsBase doesn’t have that other pharmacies might claim

It’s only fair to be transparent about what MedsBase isn’t:

  • Not LegitScript-certified. Neither is any other India-export online pharmacy — by design. Anyone claiming this in this segment is misrepresenting.
  • Not NABP-accredited. Same reason.
  • Not US-licensed. MedsBase ships from India under the international generic-export model. The medications dispensed are India-FDA / CDSCO-approved, not US-FDA-approved. They are produced by WHO-GMP manufacturers, including the same large Indian generics houses that supply the US generics market — but the finished product on your order is the Indian-market SKU.
  • Doesn’t promise express delivery. Standard transit is 10-14 business days for non-EU, 3-5 business days for in-stock EU items. We don’t claim “express tracked” because routes vary.
  • No prescription is required to order. This is a feature for our customers but it does mean the responsibility for safe use is yours. Every product page carries clinical safety information for that reason.

Frequently asked questions

Is MedsBase the only AllDayChemist alternative worth considering?

No — the international generic-pharmacy segment has several long-running operators. The criteria above are designed to help you evaluate any of them. The advantage of MedsBase is the combination of credit-card payment with chargeback rights, the Reshipment Assurance Policy in writing, and the depth of clinical information on each product page.

Will my credit card be charged by “MedsBase”?

No. Privacy Shield routes the charge through a regulated crypto on-ramp. Your bank statement will show the name of the processor (one of a regulated card-payment processor — or an abbreviation). It will never show “MedsBase” or any medication name. The full explanation is in our credit-card payment guide.

What happens if my package doesn’t arrive?

If 20 business days pass from dispatch without delivery, contact us and the Reshipment Assurance Policy applies. We arrange a free reshipment via EMS or ITPS courier. The full policy text, including customer-fault exclusions, is published at /medsbase-re-shipment-assurance-policy/.

How do you compare to other India-export online pharmacies on price?

MedsBase prices are typically within 10-20% of the segment median. We’re not the cheapest. We focus on payment options, accountability, and clinical accuracy rather than racing to the bottom on price.

Do you sell research peptides?

Yes — 21 research peptide SKUs covering BPC-157, TB-500, Ipamorelin, CJC-1295, GHK-Cu, IGF-1 LR3, Sermorelin, Tesamorelin, Retatrutide, and combination blends. Each page is research-framed and labelled “Research use only”, which is the legally accurate framing for these compounds. Peptides are not marketed as FDA-approved (because they aren’t) and ship at $0 worldwide via dedicated courier. See our peptide comparison hub for the full lineup.

What loyalty or referral programs do you have?

We run three: a points-and-rewards loyalty program (1 point per $1, 100 points = $5 off, $50 minimum cart), a customer referral program with $10 / $10 reward via REFER10, and a dormant-customer winback with 15% off via COMEBACK15 at 90 / 180 / 365 days since your last order.

Can I order from the United States?

Yes. MedsBase ships to the US, UK, EU, Australia, Canada, and most other countries. Some products with heavy-items shipping classes are removed from US orders by automated cart logic to prevent customs issues. Standard payment options apply.

Is “alternative” really the right word — or should I just stick with what I know?

If your existing pharmacy is delivering reliably and you’re satisfied with the experience, by all means stick with what works. If you’ve had reshipment denials, payment friction, suspicious post-order spam, or product pages that don’t match clinical reality, the criteria above are the ones to test against any new option. Make the decision on evidence, not just brand familiarity.

Bottom line

The international generic-pharmacy segment isn’t going away — the price gap that drives it is structural. The pharmacies worth using are the ones that take payment-method, accountability, and clinical-content responsibility seriously. MedsBase is built around those four criteria. Evaluate any pharmacy in this category against the comparison table above before placing your next order.

Related guides: How credit card payments work on MedsBase · Reshipment Assurance Policy · Best ED medications 2026 · Best finasteride brands · Best Ozempic alternatives · Best peptides for recovery · Best PrEP medications

Sophie Chen

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.